GNI Group Ltd. (2160.T)
JPY 1828.0
(0.66%)
JPY 1828.0
(0.66%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 26.01 Billion JPY | 49.32% |
| 2022 | 17.41 Billion JPY | 37.26% |
| 2021 | 12.69 Billion JPY | 29.84% |
| 2020 | 9.77 Billion JPY | 31.26% |
| 2019 | 7.44 Billion JPY | 48.36% |
| 2018 | 5.01 Billion JPY | 89.5% |
| 2017 | 2.64 Billion JPY | 102.65% |
| 2016 | 1.3 Billion JPY | 28.55% |
| 2015 | 1.01 Billion JPY | 114.16% |
| 2014 | 474.71 Million JPY | 158.56% |
| 2013 | 183.6 Million JPY | 13.37% |
| 2012 | 161.94 Million JPY | 79.28% |
| 2011 | 90.33 Million JPY | -66.9% |
| 2010 | 272.87 Million JPY | 0.0% |
| 2008 | 204.34 Million JPY | -25.31% |
| 2007 | 273.58 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.78 Billion JPY | -2.75% |
| 2024 Q1 | 5.94 Billion JPY | 8.89% |
| 2023 Q2 | 9.89 Billion JPY | 135.14% |
| 2023 Q3 | 6.45 Billion JPY | -34.77% |
| 2023 FY | 26.01 Billion JPY | 49.32% |
| 2023 Q1 | 4.2 Billion JPY | -9.7% |
| 2023 Q4 | 5.46 Billion JPY | -15.33% |
| 2022 Q1 | 3.93 Billion JPY | 24.73% |
| 2022 Q3 | 4.6 Billion JPY | 9.12% |
| 2022 Q4 | 4.65 Billion JPY | 1.12% |
| 2022 FY | 17.41 Billion JPY | 37.26% |
| 2022 Q2 | 4.22 Billion JPY | 7.32% |
| 2021 Q3 | 3.07 Billion JPY | 18.46% |
| 2021 Q1 | 3.87 Billion JPY | 37.3% |
| 2021 Q2 | 2.59 Billion JPY | -33.04% |
| 2021 FY | 12.69 Billion JPY | 29.84% |
| 2021 Q4 | 3.15 Billion JPY | 2.67% |
| 2020 Q1 | 2.12 Billion JPY | 0.65% |
| 2020 Q2 | 2.25 Billion JPY | 6.07% |
| 2020 Q3 | 2.57 Billion JPY | 14.1% |
| 2020 Q4 | 2.82 Billion JPY | 9.62% |
| 2020 FY | 9.77 Billion JPY | 31.26% |
| 2019 Q3 | 1.91 Billion JPY | 3.81% |
| 2019 Q1 | 1.57 Billion JPY | 12.38% |
| 2019 FY | 7.44 Billion JPY | 48.36% |
| 2019 Q2 | 1.84 Billion JPY | 17.06% |
| 2019 Q4 | 2.11 Billion JPY | 10.34% |
| 2018 Q2 | 1.14 Billion JPY | 13.25% |
| 2018 Q3 | 1.45 Billion JPY | 27.2% |
| 2018 Q1 | 1.01 Billion JPY | -14.56% |
| 2018 FY | 5.01 Billion JPY | 89.5% |
| 2018 Q4 | 1.4 Billion JPY | -3.87% |
| 2017 Q1 | 350.2 Million JPY | -26.48% |
| 2017 FY | 2.64 Billion JPY | 102.65% |
| 2017 Q3 | 751.68 Million JPY | 107.82% |
| 2017 Q2 | 361.68 Million JPY | 3.28% |
| 2017 Q4 | 1.18 Billion JPY | 57.63% |
| 2016 Q1 | 309.84 Million JPY | 7.78% |
| 2016 Q2 | 234.4 Million JPY | -24.35% |
| 2016 FY | 1.3 Billion JPY | 28.55% |
| 2016 Q4 | 476.33 Million JPY | 66.35% |
| 2016 Q3 | 286.34 Million JPY | 22.16% |
| 2015 FY | 1.01 Billion JPY | 114.16% |
| 2015 Q2 | 254.95 Million JPY | 9.59% |
| 2015 Q1 | 232.64 Million JPY | 16.49% |
| 2015 Q4 | 287.48 Million JPY | 19.0% |
| 2015 Q3 | 241.58 Million JPY | -5.25% |
| 2014 Q3 | 127.69 Million JPY | 39.43% |
| 2014 FY | 474.71 Million JPY | 158.56% |
| 2014 Q4 | 199.7 Million JPY | 56.39% |
| 2014 Q1 | 55.72 Million JPY | -5.62% |
| 2014 Q2 | 91.58 Million JPY | 64.35% |
| 2013 FY | 183.6 Million JPY | 13.37% |
| 2013 Q4 | 59.04 Million JPY | 21.76% |
| 2013 Q1 | 36.16 Million JPY | -12.65% |
| 2013 Q2 | 39.9 Million JPY | 10.34% |
| 2013 Q3 | 48.48 Million JPY | 21.51% |
| 2012 Q1 | 41.2 Million JPY | 11.36% |
| 2012 Q4 | 41.4 Million JPY | 38.84% |
| 2012 Q3 | 29.81 Million JPY | -39.79% |
| 2012 FY | 161.94 Million JPY | 79.28% |
| 2012 Q2 | 49.52 Million JPY | 20.19% |
| 2011 Q1 | 17.22 Million JPY | -84.8% |
| 2011 Q3 | 13.3 Million JPY | -41.68% |
| 2011 FY | 90.33 Million JPY | -66.9% |
| 2011 Q4 | 37 Million JPY | 178.2% |
| 2011 Q2 | 22.8 Million JPY | 32.39% |
| 2010 Q1 | 21.24 Million JPY | 0.0% |
| 2010 FY | 272.87 Million JPY | 0.0% |
| 2010 Q4 | 113.31 Million JPY | -4.13% |
| 2010 Q3 | 118.19 Million JPY | 487.58% |
| 2010 Q2 | 20.11 Million JPY | -5.31% |
| 2009 Q3 | 33.71 Million JPY | 32.5% |
| 2009 Q1 | 29.66 Million JPY | -35.17% |
| 2009 Q2 | 25.44 Million JPY | -14.24% |
| 2008 FY | 204.34 Million JPY | -25.31% |
| 2008 Q4 | 45.75 Million JPY | -46.68% |
| 2008 Q3 | 85.82 Million JPY | 99.11% |
| 2008 Q2 | 43.1 Million JPY | 0.0% |
| 2007 FY | 273.58 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | -445.284% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -22933.288% |
| Linical Co., Ltd. | 12.3 Billion JPY | -111.333% |
| Trans Genic Inc. | 13.08 Billion JPY | -98.805% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -3831.804% |
| Soiken Holdings Inc. | 5.15 Billion JPY | -404.232% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -1566.93% |
| AnGes, Inc. | 152.98 Million JPY | -16902.04% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -4163.203% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | -103.749% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -3084.834% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -19094.86% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -1499.775% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -5972.072% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -1268.112% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -3711.274% |
| Kidswell Bio Corporation | 2.43 Billion JPY | -969.85% |
| PeptiDream Inc. | 28.71 Billion JPY | 9.409% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -41161.733% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -21396.34% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -36125693.056% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -65110.648% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | -476.662% |
| FunPep Company Limited | 530 Thousand JPY | -4907554.906% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -37460.391% |
| Stella Pharma Corporation | 269.49 Million JPY | -9551.74% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -8109.941% |
| Cuorips Inc. | 23.1 Million JPY | -112490.126% |
| K Pharma,Inc. | 1 Billion JPY | -2501.057% |
| Takara Bio Inc. | 43.5 Billion JPY | 40.212% |
| ReproCELL Incorporated | 2.42 Billion JPY | -971.798% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -1416.368% |
| StemCell Institute Inc. | 2.48 Billion JPY | -948.309% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | -934.551% |
| CellSeed Inc. | 190.13 Million JPY | -13580.126% |